Gene · 58508
Papers4,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evolutionary history of adenomas to colorectal cancer in FAP families. | Front Genet | 2024 | 39021676 | PubTator, text mining | PubMed |
| Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes. | Am J Hum Genet | 2024 | 39013459 | PubTator, text mining | PubMed |
| Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses. | Front Pharmacol | 2024 | 38948469 | PubTator, text mining | PubMed |
| IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion. | Blood | 2024 | 38941612 | PubTator, text mining | PubMed |
| Erratum: miR-181a, delivered by hypoxic PTC-secreted exosomes, inhibits DACT2 by downregulating MLL3, leading to YAP-VEGF-mediated angiogenesis. | Mol Ther Nucleic Acids | 2024 | 38939050 | PubTator, text mining | PubMed |
| Loss of Kmt2c or Kmt2d drives brain metastasis via KDM6A-dependent upregulation of MMP3. | Nat Cell Biol | 2024 | 38926506 | PubTator, text mining | PubMed |
| Epigenetic modulators provide a path to understanding disease and therapeutic opportunity. | Genes Dev | 2024 | 38914477 | PubTator, text mining | PubMed |
| Diagnostic potential of vitreoretinal lymphoma by detection of gene mutations with NGS in 25 Chinese patients. | Clin Chim Acta | 2024 | 38909978 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. | Cancer Med | 2024 | 38895905 | PubTator, text mining | PubMed |
| Exome sequencing reveals biallelic inactivation of KMT2C in cutaneous apocrine carcinoma: A case report and review of the literature. | JAAD Case Rep | 2024 | 38883170 | PubTator, text mining | PubMed |
| ASXLs binding to the PHD2/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers. | Nat Commun | 2024 | 38849395 | PubTator, text mining | PubMed |
| Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma. | Clin Cancer Res | 2024 | 38837895 | PubTator, text mining | PubMed |
| Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma. | Cancer Immunol Immunother | 2024 | 38832974 | PubTator, text mining | PubMed |
| Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex. | Int J Mol Sci | 2024 | 38791111 | PubTator, text mining | PubMed |
| Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma. | Chin J Cancer Res | 2024 | 38751441 | PubTator, text mining | PubMed |
| Acute promyelocytic leukemia with additional chromosome abnormalities in a patient positive for HIV: A case report and literature review. | Oncol Lett | 2024 | 38694571 | PubTator, text mining | PubMed |
| Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma. | Pathol Res Pract | 2024 | 38663178 | PubTator, text mining | PubMed |
| Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics. | BMC Med Genomics | 2024 | 38609996 | PubTator, text mining | PubMed |
| KMT2C mutation as a predictor of immunotherapeutic efficacy in colorectal cancer. | Sci Rep | 2024 | 38594266 | PubTator, text mining | PubMed |
| MLL4 binds TET3. | Structure | 2024 | 38579707 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58508/papers?page=12